Hello and Welcome to Patientsville.com, Your Source for all MAGNEVIST information. We are dedicated to provide You with MAGNEVIST safety information. Learn about MAGNEVIST serious adverse events reported to Food and Drug Administration (FDA).
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
MAGNEVIST Safety Reports
Total MAGNEVIST reports: 529.MAGNEVIST FDA safety alerts: 2006 2007 .
Reported deaths: 79 Reported hospitalizations: 131.
Take MAGNEVIST Side Effects Survey or Share Your MAGNEVIST Story. Read More Here.
Showing 1-75 of 529 Next >
Health Professional from UNITED STATES reported MAGNEVIST problem on Feb 27, 2007. Female patient, 56 years of age, weighting 174.2 lb, was treated with MAGNEVIST. After drug was administered, patient experienced the following problems/side effects: pain in extremity, skin induration. MAGNEVIST dosage: 40 ML, 1 DOSE. Patient was hospitalized. Patient recovered.MAGNEVIST problem was reported by a Physician from BELGIUM on Feb 26, 2007. Male patient, 58 years of age, weighting 182.5 lb, was treated with MAGNEVIST. After drug was administered, patient experienced the following problems/side effects: back pain, cardiac murmur, coronary artery occlusion, dyspnoea, electrocardiogram qt prolonged, fatigue, gastroduodenal ulcer, intermittent claudication, nephrogenic fibrosing dermopathy. MAGNEVIST dosage: unknown. During the same period patient was treated with KAYEXALATE, ROCALTROL, GLURENORM, CORDARONE. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from ITALY reported MAGNEVIST problem on Mar 05, 2007. Male patient, 61 years of age, was treated with MAGNEVIST. After drug was administered, patient experienced the following problems/side effects: agitation, dyspnoea, feeling hot, loss of consciousness, respiratory arrest, retching. MAGNEVIST dosage: 20 ML, 1 DOSE. Patient was hospitalized. Patient recovered.
MAGNEVIST problem was reported by a Pharmacist from CANADA on Mar 02, 2007. Female patient was treated with MAGNEVIST. After drug was administered, patient experienced the following problems/side effects: incorrect dose administered, liver function test abnormal. MAGNEVIST dosage: 3 ML, 1 DOSE. Patient recovered.
Health Professional from UNITED STATES reported MAGNEVIST problem on Feb 27, 2007. Male patient, 60 years of age, weighting 147.7 lb, was treated with MAGNEVIST. After drug was administered, patient experienced the following problems/side effects: burning sensation, cardio-respiratory arrest. MAGNEVIST dosage: 15 ML, 1 DOSE. During the same period patient was treated with LIPITOR. Patient recovered.
MAGNEVIST problem was reported by a Physician from UNITED STATES on Feb 28, 2007. Female patient, 69 years of age, weighting 172.0 lb, was diagnosed with pain and was treated with MAGNEVIST. After drug was administered, patient experienced the following problems/side effects: hypoxia, nephrogenic fibrosing dermopathy. MAGNEVIST dosage: 20 ML, 1 DOSE. During the same period patient was treated with TECHNETIUM TC, GALLIUM, DARBEPOETIN ALFA, DARBEPOETIN ALFA, DARBEPOETIN ALFA, DARBEPOETIN ALFA, TRAMADOL. Patient was hospitalized. Patient recovered.
Physician from GREECE reported MAGNEVIST problem on Mar 07, 2007. Male patient, 49 years of age, was diagnosed with nuclear magnetic resonance imaging and was treated with MAGNEVIST. After drug was administered, patient experienced the following problems/side effects: burning sensation, discomfort, dyspnoea, pulse absent, tachycardia. MAGNEVIST dosage: 20 ML, 1 DOSE. Patient died on 03/06/2007.
MAGNEVIST problem was reported by a Pharmacist from UNITED STATES on Mar 12, 2007. Female patient, 47 years of age, weighting 172.0 lb, was diagnosed with nuclear magnetic resonance imaging brain and was treated with MAGNEVIST. After drug was administered, patient experienced the following problems/side effects: convulsion, feeling hot, throat irritation. MAGNEVIST dosage: unknown. Patient recovered.
Health Professional from UNITED STATES reported MAGNEVIST problem on Mar 09, 2007. Female patient, 61 years of age, was diagnosed with angiogram and was treated with MAGNEVIST. After drug was administered, patient experienced the following problems/side effects: nephrogenic fibrosing dermopathy. MAGNEVIST dosage: 50 ML, 1 DOSE. Patient recovered.
MAGNEVIST problem was reported by a Health Professional from UNITED STATES on Mar 09, 2007. Female patient, 70 years of age, was diagnosed with multiple myeloma and was treated with MAGNEVIST. After drug was administered, patient experienced the following problems/side effects: extremity contracture, mobility decreased, nephrogenic fibrosing dermopathy, skin ulcer. MAGNEVIST dosage: 40 ML, 1 DOSE. During the same period patient was treated with THALIDOMIDE. Patient recovered.
Health Professional from UNITED STATES reported MAGNEVIST problem on Mar 09, 2007. Female patient, 42 years of age, was diagnosed with angiogram and was treated with MAGNEVIST. After drug was administered, patient experienced the following problems/side effects: asthenia, mobility decreased, muscle contracture, nephrogenic fibrosing dermopathy, neuropathy peripheral, peroneal nerve palsy. MAGNEVIST dosage: 40 ML, 1 DOSE. Patient recovered.
MAGNEVIST problem was reported by a Health Professional from UNITED STATES on Mar 09, 2007. Female patient, 55 years of age, was diagnosed with nuclear magnetic resonance imaging, angiogram, neuropathy and was treated with MAGNEVIST. After drug was administered, patient experienced the following problems/side effects: abasia, arthralgia, dry skin, fall, nephrogenic fibrosing dermopathy, neuropathy peripheral, oedema peripheral, pruritus, rash. MAGNEVIST dosage: 35 ML, 1 DOSE. During the same period patient was treated with OMNISCAN, ULTRAVIST, NEURONTIN. Patient recovered.
Health Professional from UNITED STATES reported MAGNEVIST problem on Mar 09, 2007. Female patient, 52 years of age, was diagnosed with angiogram and was treated with MAGNEVIST. After drug was administered, patient experienced the following problems/side effects: burning sensation, cellulitis, gait disturbance, gout, localised infection, muscular weakness, nephrogenic fibrosing dermopathy, pain, pain in extremity. MAGNEVIST dosage: 40 ML, 1 DOSE. Patient recovered.
MAGNEVIST problem was reported by a Health Professional from UNITED STATES on Mar 09, 2007. Female patient, 68 years of age, was diagnosed with angiogram, diabetic neuropathy and was treated with MAGNEVIST. After drug was administered, patient experienced the following problems/side effects: mobility decreased, nephrogenic fibrosing dermopathy, systemic sclerosis. MAGNEVIST dosage: 40 ML, 1 DOSE. During the same period patient was treated with ULTRAVIST, NEURONTIN. Patient recovered.
Physician from UNITED STATES reported MAGNEVIST problem on Mar 21, 2007. Female patient was diagnosed with nuclear magnetic resonance imaging and was treated with MAGNEVIST. After drug was administered, patient experienced the following problems/side effects: nephrogenic fibrosing dermopathy. MAGNEVIST dosage: unknown. Patient recovered.
MAGNEVIST problem was reported by a Physician from UNITED STATES on Mar 21, 2007. Male patient was diagnosed with nuclear magnetic resonance imaging, osteomyelitis and was treated with MAGNEVIST. After drug was administered, patient experienced the following problems/side effects: nephrogenic fibrosing dermopathy. MAGNEVIST dosage: unknown. Patient recovered.
Physician from UNITED STATES reported MAGNEVIST problem on Mar 21, 2007. Female patient was diagnosed with carotid artery disease and was treated with MAGNEVIST. After drug was administered, patient experienced the following problems/side effects: dialysis, hypotension, nephrogenic fibrosing dermopathy. MAGNEVIST dosage: 20 ML SINGLE DOSE IV BOLUS. Patient recovered.
MAGNEVIST problem was reported by a Health Professional from BELGIUM on Mar 15, 2007. Male patient, 80 years of age, was treated with MAGNEVIST. After drug was administered, patient experienced the following problems/side effects: bronchospasm, cardiac arrest, myocardial ischaemia. MAGNEVIST dosage: unknown. During the same period patient was treated with ASAFLOW. Patient was hospitalized. Patient recovered.
Physician from UNITED STATES reported MAGNEVIST problem on Mar 12, 2007. Male patient, 75 years of age, weighting 227.1 lb, was diagnosed with nuclear magnetic resonance imaging and was treated with MAGNEVIST. After drug was administered, patient experienced the following problems/side effects: nephrogenic fibrosing dermopathy, renal failure acute. MAGNEVIST dosage: 29 ML, 1 DOSE (ESTIMATED). During the same period patient was treated with FUROSEMIDE, COREG. Patient recovered.
MAGNEVIST problem was reported by a Health Professional from UNITED STATES on Mar 22, 2007. Female patient, 29 years of age, was diagnosed with breast mass and was treated with MAGNEVIST. After drug was administered, patient experienced the following problems/side effects: chest discomfort, urticaria. MAGNEVIST dosage: unknown. Patient was hospitalized. Patient recovered.
Health Professional from UNITED STATES reported MAGNEVIST problem on Mar 22, 2007. Female patient, weighting 160.0 lb, was diagnosed with back pain and was treated with MAGNEVIST. After drug was administered, patient experienced the following problems/side effects: erythema, induration, oedema peripheral. MAGNEVIST dosage: 15ML ONCE IV. Patient recovered.
MAGNEVIST problem was reported by a Health Professional from UNITED STATES on Mar 22, 2007. Female patient, weighting 140.0 lb, was diagnosed with pituitary tumour and was treated with MAGNEVIST. After drug was administered, patient experienced the following problems/side effects: eyelid disorder, urticaria. MAGNEVIST dosage: 10ML ONCE IV. Patient recovered.
Health Professional from SPAIN reported MAGNEVIST problem on Mar 15, 2007. Male patient, 51 years of age, weighting 187.4 lb, was treated with MAGNEVIST. After drug was administered, patient experienced the following problems/side effects: nephrogenic fibrosing dermopathy. MAGNEVIST dosage: 40 ML, 1 DOSE. During the same period patient was treated with MASTICAL, ALLOPURINOL, ARANESP, MANIDIPINE HYDROCHLORIDE, IRBESARTAN, LYMETEL, OMEPRAZOLE, SEGURIL. Patient recovered.
MAGNEVIST problem was reported by a Physician from UNITED STATES on Mar 17, 2007. Male patient, 62 years of age, was diagnosed with hypertension, vitamin supplementation and was treated with MAGNEVIST. After drug was administered, patient experienced the following problems/side effects: nephrogenic fibrosing dermopathy, pulmonary fibrosis, respiratory failure. MAGNEVIST dosage: 20 ML, 1 DOSE. During the same period patient was treated with EPOGEN, INSULIN, METOPROLOL SUCCINATE, SIMVASTATIN, NEPHRO, DEPAKOTE, ASCORBIC ACID. Patient was hospitalized. Patient died.
Consumer or non-health professional from ITALY reported MAGNEVIST problem on Mar 19, 2007. Male patient, 61 years of age, was treated with MAGNEVIST. After drug was administered, patient experienced the following problems/side effects: agitation, cerebral infarction, coma, dyspnoea, feeling hot, respiratory arrest, retching, unevaluable event. MAGNEVIST dosage: 20 ML, 1 DOSE. During the same period patient was treated with CHLORIDE. Patient was hospitalized. Patient recovered.
MAGNEVIST problem was reported by a Health Professional from UNITED STATES on Mar 20, 2007. Female patient was treated with MAGNEVIST. After drug was administered, patient experienced the following problems/side effects: nephrogenic fibrosing dermopathy. MAGNEVIST dosage: unknown. Patient recovered.
Health Professional from CANADA reported MAGNEVIST problem on Mar 20, 2007. Male patient, 60 years of age, was treated with MAGNEVIST. After drug was administered, patient experienced the following problems/side effects: nephrogenic fibrosing dermopathy. MAGNEVIST dosage: 15 ML, 1 DOSE. During the same period patient was treated with CONTRAST MEDIA. Patient recovered.
MAGNEVIST problem was reported by a Consumer or non-health professional from NORWAY on Mar 19, 2007. Male patient, 63 years of age, was treated with MAGNEVIST. After drug was administered, patient experienced the following problems/side effects: nephrogenic fibrosing dermopathy. MAGNEVIST dosage: unknown. Patient died on 12/14/2005.
Physician from UNITED STATES reported MAGNEVIST problem on Mar 09, 2007. Male patient, 42 years of age, was treated with MAGNEVIST. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation, nephrogenic fibrosing dermopathy. MAGNEVIST dosage: 30 ML, 1 DOSE. Patient recovered.
MAGNEVIST problem was reported by a Health Professional from UNITED STATES on Mar 21, 2007. Female patient, 67 years of age, weighting 154.3 lb, was treated with MAGNEVIST. After drug was administered, patient experienced the following problems/side effects: dysuria, erythema, eye swelling, swelling face, urticaria. MAGNEVIST dosage: 25 ML, 1 DOSE. During the same period patient was treated with ANTINEOPLASTIC AGENTS. Patient was hospitalized. Patient recovered.
Physician from GREECE reported MAGNEVIST problem on Mar 23, 2007. Female patient, 36 years of age, weighting 165.3 lb, was diagnosed with diagnostic procedure and was treated with MAGNEVIST. After drug was administered, patient experienced the following problems/side effects: cough, nasal congestion, salivary hypersecretion. MAGNEVIST dosage: 20 ML, 1 DOSE. Patient recovered.
MAGNEVIST problem was reported by a Physician from GERMANY on Mar 24, 2007. Male patient was diagnosed with nuclear magnetic resonance imaging and was treated with MAGNEVIST. After drug was administered, patient experienced the following problems/side effects: nephrogenic fibrosing dermopathy. MAGNEVIST dosage: 32 ML, 1 DOSE. During the same period patient was treated with OMNISCAN. Patient recovered.
Health Professional from SPAIN reported MAGNEVIST problem on Mar 28, 2007. Male patient, 51 years of age, weighting 187.4 lb, was treated with MAGNEVIST. After drug was administered, patient experienced the following problems/side effects: nephrogenic fibrosing dermopathy. MAGNEVIST dosage: 40 ML, 1 DOSE. During the same period patient was treated with MASTICAL, ALLOPURINOL, ARANESP, MANIDIPINE HYDROCHLORIDE, IRBESARTAN, LYMETEL, OMEPRAZOLE, SEGURIL. Patient recovered.
MAGNEVIST problem was reported by a Health Professional from UNITED STATES on Apr 03, 2007. Female patient, weighting 115.0 lb, was diagnosed with pelvic pain and was treated with MAGNEVIST. After drug was administered, patient experienced the following problems/side effects: urticaria. MAGNEVIST dosage: 10ML ONCE IV. Patient recovered.
Physician from UNITED STATES reported MAGNEVIST problem on Mar 29, 2007. Female patient was treated with MAGNEVIST. After drug was administered, patient experienced the following problems/side effects: nephrogenic fibrosing dermopathy. MAGNEVIST dosage: 12 ML, 1 DOSE. During the same period patient was treated with OMNISCAN. Patient recovered.
MAGNEVIST problem was reported by a Physician from UNITED STATES on Mar 29, 2007. Female patient was treated with MAGNEVIST. After drug was administered, patient experienced the following problems/side effects: nephrogenic fibrosing dermopathy. MAGNEVIST dosage: unknown. During the same period patient was treated with OMNISCAN. Patient recovered.
Physician from UNITED STATES reported MAGNEVIST problem on Mar 29, 2007. Female patient was treated with MAGNEVIST. After drug was administered, patient experienced the following problems/side effects: nephrogenic fibrosing dermopathy. MAGNEVIST dosage: 40 ML, 1 DOSE. During the same period patient was treated with OMNISCAN. Patient recovered.
MAGNEVIST problem was reported by a Physician from UNITED STATES on Mar 29, 2007. Female patient was treated with MAGNEVIST. After drug was administered, patient experienced the following problems/side effects: nephrogenic fibrosing dermopathy. MAGNEVIST dosage: unknown. During the same period patient was treated with OMNISCAN. Patient recovered.
Consumer or non-health professional from ITALY reported MAGNEVIST problem on Mar 29, 2007. Male patient, 61 years of age, was treated with MAGNEVIST. After drug was administered, patient experienced the following problems/side effects: agitation, cerebral infarction, coma, dyspnoea, feeling hot, respiratory arrest, retching, unevaluable event. MAGNEVIST dosage: 20 ML, 1 DOSE. During the same period patient was treated with CHLORIDE. Patient was hospitalized. Patient recovered.
MAGNEVIST problem was reported by a Physician from UNITED STATES on Apr 02, 2007. Female patient was treated with MAGNEVIST. After drug was administered, patient experienced the following problems/side effects: nephrogenic fibrosing dermopathy. MAGNEVIST dosage: unknown. Patient recovered.
Consumer or non-health professional from NORWAY reported MAGNEVIST problem on Apr 10, 2007. Male patient, 63 years of age, was treated with MAGNEVIST. After drug was administered, patient experienced the following problems/side effects: nephrogenic fibrosing dermopathy. MAGNEVIST dosage: unknown. Patient died on 12/14/2005.
MAGNEVIST problem was reported by a Health Professional from UNITED STATES on Apr 12, 2007. Male patient, weighting 156.0 lb, was diagnosed with nuclear magnetic resonance imaging and was treated with MAGNEVIST. After drug was administered, patient experienced the following problems/side effects: dialysis, nephrogenic fibrosing dermopathy. MAGNEVIST dosage: 20ML 2ML/SEC IV BOLUS. Patient recovered.
Physician from UNITED STATES reported MAGNEVIST problem on Apr 12, 2007. Male patient, 79 years of age, weighting 156.5 lb, was diagnosed with angiogram and was treated with MAGNEVIST. After drug was administered, patient experienced the following problems/side effects: anaemia, anxiety, asthenia, blood glucose increased, blood pressure decreased, bronchitis, cardiac failure, dehydration, depression. MAGNEVIST dosage: unknown. During the same period patient was treated with BETAPACE, ALLOPURINOL, HYDRALAZINE, PROCARDIA. Patient was hospitalized. Patient recovered.
MAGNEVIST problem was reported by a Physician from GERMANY on Apr 12, 2007. Male patient, 64 years of age, was treated with MAGNEVIST. After drug was administered, patient experienced the following problems/side effects: acalculia, aggression, anterograde amnesia, confusional state, coordination abnormal, delirium, disorientation, disturbance in attention, dysarthria. MAGNEVIST dosage: 20 ML, 1 DOSE. During the same period patient was treated with ISOVIST. Patient was hospitalized. Patient recovered.
Health Professional from UNITED STATES reported MAGNEVIST problem on Apr 13, 2007. Male patient, 35 years of age, weighting 160.9 lb, was treated with MAGNEVIST. After drug was administered, patient experienced the following problems/side effects: dyskinesia, dysphagia, nephrogenic fibrosing dermopathy, speech disorder, tongue disorder. MAGNEVIST dosage: unknown. Patient was hospitalized and became disabled. Patient recovered.
MAGNEVIST problem was reported by a Physician from UNITED STATES on Apr 16, 2007. Male patient, 73 years of age, was treated with MAGNEVIST. After drug was administered, patient experienced the following problems/side effects: nephrogenic fibrosing dermopathy, serum ferritin increased. MAGNEVIST dosage: 20 ML, 1 DOSE. Patient died on 05/06/2006.
Physician from UNITED STATES reported MAGNEVIST problem on Apr 16, 2007. Male patient, 73 years of age, was treated with MAGNEVIST. After drug was administered, patient experienced the following problems/side effects: nephrogenic fibrosing dermopathy, serum ferritin increased. MAGNEVIST dosage: 40 ML, 1 DOSE. Patient recovered.
MAGNEVIST problem was reported by a Health Professional from UNITED STATES on Apr 13, 2007. Female patient, 60 years of age, weighting 176.4 lb, was diagnosed with nuclear magnetic resonance imaging brain, angina pectoris, hypertension and was treated with MAGNEVIST. After drug was administered, patient experienced the following problems/side effects: anaphylactic shock, anxiety, arthralgia, blood creatinine increased, blood urea increased, chest pain, circulatory collapse, dyspnoea, hypotension. MAGNEVIST dosage: 15 ML, 1 DOSE. During the same period patient was treated with NITROGLYCERIN. Patient was hospitalized. Patient recovered.
Physician from UNITED STATES reported MAGNEVIST problem on Apr 16, 2007. Female patient, 60 years of age, was treated with MAGNEVIST. After drug was administered, patient experienced the following problems/side effects: nephrogenic fibrosing dermopathy, serum ferritin increased. MAGNEVIST dosage: 50 ML, 1 DOSE. Patient recovered.
MAGNEVIST problem was reported by a Physician from UNITED STATES on Apr 16, 2007. Female patient, 52 years of age, was treated with MAGNEVIST. After drug was administered, patient experienced the following problems/side effects: nephrogenic fibrosing dermopathy, serum ferritin increased. MAGNEVIST dosage: 20 ML, 1 DOSE. Patient died on 07/28/2002.
Physician from UNITED STATES reported MAGNEVIST problem on Apr 16, 2007. Male patient, 62 years of age, was treated with MAGNEVIST. After drug was administered, patient experienced the following problems/side effects: nephrogenic fibrosing dermopathy. MAGNEVIST dosage: 20 ML, 1 DOSE. Patient recovered.
MAGNEVIST problem was reported by a Physician from FRANCE on Apr 16, 2007. Male patient, 52 years of age, weighting 176.4 lb, was diagnosed with nuclear magnetic resonance imaging and was treated with MAGNEVIST. After drug was administered, patient experienced the following problems/side effects: metastases to lung, paraneoplastic syndrome. MAGNEVIST dosage: unknown. Patient recovered.
Physician from UNITED STATES reported MAGNEVIST problem on Apr 20, 2007. Female patient was treated with MAGNEVIST. After drug was administered, patient experienced the following problems/side effects: nephrogenic fibrosing dermopathy. MAGNEVIST dosage: 40 ML, 1 DOSE. During the same period patient was treated with OMNISCAN. Patient recovered.
MAGNEVIST problem was reported by a Physician from UNITED STATES on Apr 16, 2007. Female patient, 50 years of age, was treated with MAGNEVIST. After drug was administered, patient experienced the following problems/side effects: nephrogenic fibrosing dermopathy, serum ferritin increased. MAGNEVIST dosage: 20 ML, 1 DOSE. Patient recovered.
Physician from UNITED STATES reported MAGNEVIST problem on Apr 16, 2007. Female patient, 59 years of age, was treated with MAGNEVIST. After drug was administered, patient experienced the following problems/side effects: nephrogenic fibrosing dermopathy, serum ferritin increased. MAGNEVIST dosage: 40 ML, 1 DOSE. Patient died on 11/03/2005.
MAGNEVIST problem was reported by a Physician from UNITED STATES on Apr 16, 2007. Male patient, 79 years of age, was diagnosed with nuclear magnetic resonance imaging abdominal and was treated with MAGNEVIST. After drug was administered, patient experienced the following problems/side effects: nephrogenic fibrosing dermopathy, serum ferritin increased. MAGNEVIST dosage: 20 ML, 1 DOSE. Patient recovered.
Consumer or non-health professional from UNITED STATES reported MAGNEVIST problem on Apr 20, 2007. Female patient, 69 years of age, weighting 172.0 lb, was diagnosed with pain and was treated with MAGNEVIST. After drug was administered, patient experienced the following problems/side effects: hypoxia, nephrogenic fibrosing dermopathy. MAGNEVIST dosage: 20 ML, 1 DOSE. During the same period patient was treated with TECHNETIUM TC, GALLIUM, DARBEPOETIN ALFA, DARBEPOETIN ALFA, DARBEPOETIN ALFA, DARBEPOETIN ALFA, TRAMADOL. Patient was hospitalized. Patient recovered.
MAGNEVIST problem was reported by a Health Professional from UNITED STATES on Apr 19, 2007. Male patient, 56 years of age, was treated with MAGNEVIST. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, loss of consciousness, nasal congestion, respiratory distress. MAGNEVIST dosage: 40 ML, 1 DOSE. Patient died on 04/20/2007.
Health Professional from UNITED STATES reported MAGNEVIST problem on Apr 12, 2007. Male patient, 53 years of age, was treated with MAGNEVIST. After drug was administered, patient experienced the following problems/side effects: mass, nephrogenic fibrosing dermopathy, upper extremity mass. MAGNEVIST dosage: 14 ML, 1 DOSE. Patient recovered.
MAGNEVIST problem was reported by a Health Professional from CANADA on Apr 17, 2007. Male patient, 60 years of age, was treated with MAGNEVIST. After drug was administered, patient experienced the following problems/side effects: nephrogenic fibrosing dermopathy. MAGNEVIST dosage: 15 ML, 1 DOSE. During the same period patient was treated with CONTRAST MEDIA, OMNISCAN. Patient recovered.
Health Professional from UNITED STATES reported MAGNEVIST problem on Apr 18, 2007. Female patient, 49 years of age, was treated with MAGNEVIST. After drug was administered, patient experienced the following problems/side effects: abdominal pain, back pain, dyspnoea, respiratory arrest, skin discolouration. MAGNEVIST dosage: 17 ML, 1 DOSE. Patient recovered.
MAGNEVIST problem was reported by a Physician from GERMANY on Apr 20, 2007. Male patient, 64 years of age, was treated with MAGNEVIST. After drug was administered, patient experienced the following problems/side effects: acalculia, aggression, anterograde amnesia, confusional state, coordination abnormal, delirium, disorientation, disturbance in attention, dysarthria. MAGNEVIST dosage: 20 ML, 1 DOSE. During the same period patient was treated with ISOVIST. Patient was hospitalized. Patient recovered.
Physician from GERMANY reported MAGNEVIST problem on Apr 19, 2007. Male patient, 76 years of age, weighting 172.0 lb, was treated with MAGNEVIST. After drug was administered, patient experienced the following problems/side effects: abdominal pain, arthralgia, dizziness, feeling cold, headache, hyperhidrosis, joint swelling, local swelling, nausea. MAGNEVIST dosage: 18 ML, 1 DOSE. Patient was hospitalized. Patient recovered.
MAGNEVIST problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 30, 2007. Female patient, weighting 180.0 lb, was diagnosed with angiogram and was treated with MAGNEVIST. After drug was administered, patient experienced the following problems/side effects: arthralgia, carpal tunnel syndrome, hypertension, muscular weakness, musculoskeletal chest pain, neuropathy peripheral, plantar fasciitis, rash, renal failure chronic. MAGNEVIST dosage: 20ML ONCE. Patient was hospitalized. Patient recovered.
Physician from UNITED STATES reported MAGNEVIST problem on Apr 16, 2007. Female patient was diagnosed with scan and was treated with MAGNEVIST. After drug was administered, patient experienced the following problems/side effects: nephrogenic fibrosing dermopathy. MAGNEVIST dosage: 2 SCANS WITH 15 ML. Patient recovered.
MAGNEVIST problem was reported by a Physician from UNITED STATES on Apr 16, 2007. Female patient was diagnosed with scan and was treated with MAGNEVIST. After drug was administered, patient experienced the following problems/side effects: nephrogenic fibrosing dermopathy. MAGNEVIST dosage: 4 SCANS 20-40 ML. Patient recovered.
Physician from UNITED STATES reported MAGNEVIST problem on Apr 16, 2007. Female patient was treated with MAGNEVIST. After drug was administered, patient experienced the following problems/side effects: nephrogenic fibrosing dermopathy. MAGNEVIST dosage: 15 ML 6 TIMES. Patient recovered.
MAGNEVIST problem was reported by a Physician from UNITED STATES on Apr 25, 2007. Male patient, 79 years of age, weighting 156.5 lb, was diagnosed with angiogram and was treated with MAGNEVIST. After drug was administered, patient experienced the following problems/side effects: anaemia, anxiety, asthenia, blood glucose increased, blood pressure decreased, cardiac failure, dehydration, depression, dizziness. MAGNEVIST dosage: unknown. During the same period patient was treated with BETAPACE, ALLOPURINOL, HYDRALAZINE, PROCARDIA, ECOTRIN, COLCHICINE, NEXIUM. Patient was hospitalized. Patient recovered.
Health Professional from UNITED STATES reported MAGNEVIST problem on May 09, 2007. Male patient, 59 years of age, weighting 173.0 lb, was diagnosed with neuropathy peripheral and was treated with MAGNEVIST. After drug was administered, patient experienced the following problems/side effects: nephrogenic fibrosing dermopathy. MAGNEVIST dosage: 15ML ONCE IV BOLUS. Patient recovered.
MAGNEVIST problem was reported by a Health Professional from UNITED STATES on May 01, 2007. Male patient, 43 years of age, was diagnosed with nuclear magnetic resonance imaging and was treated with MAGNEVIST. After drug was administered, patient experienced the following problems/side effects: antibody test positive, arteriosclerosis coronary artery, bone cyst, catheter related infection, catheter sepsis, cellulitis, enterococcal sepsis, hypotension. MAGNEVIST dosage: 20 ML, 1 DOSE. During the same period patient was treated with RENAGEL, NEPHROCAPS, LEVOXYL. Patient died on 08/01/2004.
Consumer or non-health professional from GERMANY reported MAGNEVIST problem on May 02, 2007. Male patient was treated with MAGNEVIST. After drug was administered, patient experienced the following problems/side effects: nephrogenic fibrosing dermopathy. MAGNEVIST dosage: 41 ML, 1 DOSE. During the same period patient was treated with OMNISCAN. Patient recovered.
MAGNEVIST problem was reported by a Consumer or non-health professional from GERMANY on May 02, 2007. Female patient, 69 years of age, was treated with MAGNEVIST. After drug was administered, patient experienced the following problems/side effects: nephrogenic fibrosing dermopathy. MAGNEVIST dosage: 24 ML, 1 DOSE. During the same period patient was treated with OMNISCAN. Patient recovered.
Health Professional from CANADA reported MAGNEVIST problem on May 03, 2007. Male patient, 60 years of age, was diagnosed with computerised tomogram and was treated with MAGNEVIST. After drug was administered, patient experienced the following problems/side effects: nephrogenic fibrosing dermopathy. MAGNEVIST dosage: 15 ML, 1 DOSE. During the same period patient was treated with CONTRAST MEDIA, OMNISCAN, BACLOFEN, CARBAMAZEPINE, VITAMIN B, DOCUSATE, DOMPERIDONE, FUROSEMIDE. Patient recovered.
MAGNEVIST problem was reported by a Physician from UNITED STATES on May 01, 2007. Female patient, 56 years of age, was diagnosed with angiogram and was treated with MAGNEVIST. After drug was administered, patient experienced the following problems/side effects: atrioventricular block second degree, blood glucose increased, carotid artery stenosis, chest discomfort, coronary artery stenosis, dry skin, dyspnoea exertional, electrocardiogram t wave inversion, glycosylated haemoglobin increased. MAGNEVIST dosage: unknown. During the same period patient was treated with NORVASC, LISINOPRIL, PLAVIX, LASIX, ATENOLOL, ZESTRIL. Patient died on 01/01/2005.
Consumer or non-health professional from GERMANY reported MAGNEVIST problem on May 02, 2007. Male patient was diagnosed with nuclear magnetic resonance imaging and was treated with MAGNEVIST. After drug was administered, patient experienced the following problems/side effects: nephrogenic fibrosing dermopathy. MAGNEVIST dosage: 32 ML, 1 DOSE. During the same period patient was treated with OMNISCAN. Patient recovered.
Showing 1-75 of 529 Next >